Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review
Authors:
- 1 September 2020
- journal article
- review article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 252, 100-104
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Proportion of Cytotoxic Peripheral Blood Natural Killer Cells and T-Cell Large Granular Lymphocytes in Recurrent Miscarriage and Repeated Implantation Failure: Case–Control Study and Meta-analysisArchivum Immunologiae et Therapiae Experimentalis, 2019
- Intralipid® may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activationJournal of Reproductive Immunology, 2018
- RETRACTED: Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cellsInternational Journal of Gynecology & Obstetrics, 2016
- The Uterine Immune Profile May Help Women With Repeated Unexplained Embryo Implantation Failure After In Vitro FertilizationAmerican Journal of Reproductive Immunology, 2016
- Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortionArchives of Gynecology and Obstetrics, 2015
- Changes and clinical significance of peripheral blood helper T lymphocyte and natural killer (NK) cells in unexplained recurrent spontaneous abortion (URSA) patients after abortion and successful pregnancyClinical and Experimental Obstetrics & Gynecology, 2015
- Recurrent implantation failure: definition and managementReproductive BioMedicine Online, 2014
- Recurrent miscarriageThe Lancet, 2006
- Effects of Parenteral Lipid Emulsions With Different Fatty Acid Composition on Immune Cell Functions In VitroJournal of Parenteral and Enteral Nutrition, 2000
- Intralipid as Treatment for Recurrent Unexplained Abortion?American Journal of Reproductive Immunology, 1994